Holdings
Logos Global Management LP
As of Jun 30, 2026, Logos Global Management LP reported 60 positions worth US$2.04B. Largest: Erasca, Inc., Abivax Sa and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Erasca, Inc. | 12.2M | US$223M | +1M | Jun 30, 2026 |
| Abivax Sa | 1.02M | US$136M | +349K | Jun 30, 2026 |
| Revolution Medicines, Inc. | 700K | US$131M | −1.3M | Jun 30, 2026 |
| Ideaya Biosciences, Inc. | 3M | US$112M | −450K | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 2.2M | US$94.4M | new | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 2.85M | US$89.1M | −150K | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 260K | US$87M | −25,000 | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 2.1M | US$78.1M | +1.65M | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 800K | US$78M | +400K | Jun 30, 2026 |
| Cg Oncology, Inc. | 1M | US$71M | +425K | Jun 30, 2026 |